You are here

Home / Resources / Key Material
Export 82 results:
Filters: First Letter Of Last Name is T  [Clear All Filters]
D
Haas, C. N., & Thayyar-Madabusi A. (1999).  Development and Validation of Dose-Response Relationship for Listeria monocytogenes. Quantitative Microbiology. 1, 89-102.
Teunis, P.., Takumi K.., & Shinagawa K.. (2004).  Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
Teunis, P.., Takumi K.., & Shinagawa K.. (2004).  Dose response for infection by Escherichia coli O157:H7 from outbreak data. Risk Analysis: An Official Publication of the Society for Risk Analysis. 24, 401-407.
Chen, L., Geys H., Cawthraw S., Havelaar A., & Teunis P. (2006).  Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis. 26, 1613–1621.
Chen, L.., Geys H.., Cawthraw S.., Havelaar A.., & Teunis P.. (2006).  Dose response for infectivity of several strains of ''Campylobacter jejuni'' in chickens. Risk Analysis. 1613-1621.
Chen, L.., Geys H.., Cawthraw S.., Havelaar A.., & Teunis P.. (2006).  Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Analysis: An Official Publication of the Society for Risk Analysis. 26, 1613-1621.
Chen, L.., Geys H.., Cawthraw S.., Havelaar A.., & Teunis P.. (2006).  Dose Response for Infectivity of Several Strains of Campylobacter jejuni in Chickens. Risk Analysis. 26, 6.
Teunis, P. F. M., Nagelkerke N. J. D., & Haas C. N. (1999).  Dose response models for infectious gastroenteritis. Risk Analysis. 19, 1251–1260.
Murphy, B. R., Clements M. L., Tierney E. L., Black R. E., Stienberg J., & Chanock R. M. (1985).  Dose Response of Influenza A/Washington/897/80 (H3N2) Avian-Human Reassortant Virus in Adult Volunteers. The Journal of Infectious Diseases. 152, 1.
Smith, M. A., Takeuchi K., Anderson G., Ware G. O., McClure H. M., Raybourne R. B., et al. (2008).  Dose-Response Model for Listeria monocytogenes-Induced Stillbirths in Nonhuman Primates. Infection and Immunity. 76, 2.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand T. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120–128.
Tamrakar, S. B., Haluska A., Haas C. N., & Bartrand B. A. (2011).  Dose-Response Model of Coxiella burnetii (Q Fever). Risk Analysis. 31, 120-128.
E
Chen, Y. Sen, Lin YE., Liu Y-C., Huang W. Kuei, Shih HY., Wann S. Ren, et al. (2008).  Efficacy of point-of-entry copper–silver ionisation system in eradicating Legionella pneumophila in a tropical tertiary care hospital: implications for hospitals contaminated with Legionella in both hot and cold water. Journal of Hospital Infection. 68, 152–158.
Mishra, A., Taneja N., & Sharma M. (2012).  Environmental and epidemiological surveillance of Vibrio cholerae in a cholera-endemic region in India with freshwater environs. Journal of applied microbiology. 112, 225–237.
F
Titball, R. W., & Sjostedt A. (2003).  Francisella tularensis: an overview. American Society for Microbiology News. 69, 558-563.
Thomas, V., McDonnell G., Denyer S. P., & Maillard J-Y. (2010).  Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS microbiology reviews. 34, 231–259.
H
Horsman, J.., Furlong W.., Feeny D.., & Torrance G.. (2003).  The Health Utilities Index (HUI): concepts, measurement properties and applications. Health and Quality of Life Outcomes. 1, 54.
Al-Abdallat, M. Mousa, Payne D. C., Alqasrawi S., Rha B., Tohme R. A., Abedi G. R., et al. (2014).  Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clinical Infectious Diseases. 59, 1225–1233.
Minor, T.. E., Allen C.. I., Tsiatis A.. A., Nelson D.. B., & D’Alessio D.. J. (1981).  Human infective dose determinations for oral poliovirus type 1 vaccine in infants. Journal of Clinical Microbiology. 13, 2.
I
Coster, T. S., Wolf M. K., Hall E. R., Cassels F. J., Taylor D. N., Liu C. T., et al. (2007).  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75, 1.
Coster, T. S., Wolf M. K., Hall E. R., Cassels F. J., Taylor D. N., Liu C. T., et al. (2007).  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity. 75, 1.
Taylor, D. M., Woodgate S. L., & Atkinson M. J. (1995).  Inactivation of the bovine spongiform encephalopathy agent by rendering procedures. Veterinary Record. 137(24), 
Bhengsri, S.., Baggett H.. C., Jorakate P.., Kaewpan A.., Prapasiri P.., Naorat S.., et al. (2011).  Incidence of Bacteremic Melioidosis in Eastern and Northeastern Thailand. The American Journal of Tropical Medicine and Hygiene. 85, 1.
Okhuysen, P. C., Rich S. M., Chappell C. L., Grimes K. A., Widmer G., Feng X., et al. (2002).  Infectivity of a Cryptosporidium parvum Isolate of Cervine Origin for Healthy Adults and Interferon-γ Knockout Mice. Journal of Infectious Diseases. 185, 9.
K
Bradford, W.. D., Croker B.. P., & Tisher C.. C. (1979).  Kidney lesions in Rocky Mountain spotted fever. A light-, immunofluorescence-, and electron-microscopic study. Am. J. Pathol. 97, 381-390.